Business Wire

Revance Submits Biologics License Application (BLA) to the FDA for DAXI to Treat Glabellar (Frown) Lines

Revance has successfully completed a Phase 3 program for DAXI in glabellar (frown) lines and is pursuing U.S. regulatory approval in 2020. Revance is also evaluating DAXI in forehead lines and lateral ...
Business Insider

Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines

NEWPORT BEACH, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today ...
Healio

Repeated injections of relabotulinumtoxinA safe long term for frown lines, crow’s feet

Please provide your email address to receive an email when new articles are posted on . 43.9% of patients experienced a treatment-emergent adverse event. Only 18.2% were treatment related. Efficacy ...
Healio

Increased incobotulinumtoxinA doses prolong frown line reduction

Please provide your email address to receive an email when new articles are posted on . IncobotulinumtoxinA was effective and safe in the reduction of glabellar frown lines at multiple dose levels, ...
Business Wire

Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation botulinumtoxinA (RelabotulinumtoxinA) for the Treatment of Glabellar Lines (frown ...

Both studies met their primary endpoints with significantly higher response than placebo after one month for both frown lines and crow’s feet Results showed rapid onset of action with median response ...
Daily Mail

Is your frown losing you friends? Why women are paying THOUSANDS to have their 'resting b*tch face' removed

Australian women who are affected by 'resting b*tch face', or RBF, are spending thousands of dollars to have their frown lines, down-turned mouths and 'unfriendly appearance' softened. Cosmetic ...